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Introduction
In March, 2006, the State Council of the People’s Republic 
of China offi  cially announced the fi rst legislation directly 
aimed at controlling HIV/AIDS: the AIDS Prevention 
and Control Regulations.1 These regulations, together 
with the Five-Year Action Plan to Control HIV/AIDS 
(2006–2010),2 are an important step in the development 
of government policy related to the care and prevention 
of HIV/AIDS. Although bold, these regulations were 
passed more than 20 years after the fi rst case of HIV 
infection was identifi ed. The development of a coherent 
policy was the result of a long and unsystematic process 
that involved initial mis-steps, considerable domestic and 
international education, debate, iterative trial-and-error 
learning, and scientifi c studies. The new legislation 
resulted from communication and coordination among 
many agencies, including administrators, service 
providers, politicians, the scientifi c community, and 
policymakers. We describe the infl uence of scientifi c 
studies and other factors on the development of HIV/
AIDS policy in China and provide a timeline of important 
milestones in the development of the current policy 
(fi gure 1). This review is intended as a general overview 
of progress in China and does not attempt to provide a 
detailed account of province-to-province variation in the 
evolution and implementation of HIV prevention and 
control strategies. 
Overview of the epidemic
China’s fi rst AIDS case was identifi ed in 1985 in a dying 
tourist.3 In 1989, the fi rst indigenous cases were 
reported as an outbreak in 146 infected heroin users in 
Yunnan province, near China’s southwest border.4 
Between 1989 and the mid-1990s, HIV spread steadily 
from Yunnan into neighbouring areas and along the 
major drug traffi  cking routes, then from injecting drug 
users (IDUs) to their sexual partners and children. In 
the mid-1990s, the occurrence of a second major 
outbreak in commercial plasma donors in the 
east-central provinces became apparent.5 Plasma donors 
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Figure 1: Important events in China’s HIV/AIDS policy development, 1985–2006
ART=antiretroviral therapy. MMT=methadone maintenance treatment. NEP=needle exchange programme. PMTCT=prevention of mother-to-child transmission. 
Public Health
680 www.thelancet.com   Vol 369   February 24, 2007 
were paid to donate blood, the plasma removed, then 
the red blood cells reinfused to prevent anaemia. Reuse 
of tubing and mixing during collection and reinfusion 
led to thousands of new infections.6,7 At the same time, 
HIV was also spreading through sexual transmission. 
By 1998, HIV had reached all 31 provinces and was in a 
phase of exponential growth (fi gure 2),8 which, by 2005, 
had culminated in an estimated 650 000 infections.9
Early control strategies
Initially, the Chinese government focused its preventive 
strategies on stopping HIV from entering the country. 
Regulations were introduced that required foreigners 
who intended to stay 1 year or more and Chinese 
residents returning from overseas to have an HIV 
test.10–12 All imported blood products were banned.13,14 
There were attempts to stop transmission within the 
country as well—eg, laws against drug use15 and 
prostitution16 were strengthened and authorities were 
allowed to isolate HIV-positive individuals.12 In much 
the same way as other countries, traditional public-health 
methods of containment and isolation of infectious 
disease cases proved ineff ective.17 Containment policies 
occurred in the context of rapid social and economic 
change, in which there were increases in drug use and 
changing sexual mixing patterns. These early policies 
did little to stop transmission of HIV; in fact, they 
probably promoted concealment of risk activities and 
made identifi cation of HIV reservoirs more diffi  cult.18–20 
Information and communication networks  
The attitudes of government offi  cials shifted substantially 
over time, a result of increasing scientifi c evidence that 
Chinese people were becoming infected, the dramatic 
devastation caused by HIV/AIDS in other countries, and 
research in China that showed that HIV transmission 
could be reduced with targeted interventions. 
As early as the mid-1990s, Chinese offi  cials began to 
organise study tours to learn from the successes and 
failures of other countries in combating HIV/AIDS and 
to bring back information about strategies for HIV/AIDS 
control that could be adapted for China. Tour groups 
including offi  cials from the Ministries of Health, Public 
Security, Justice, Education and Finance, Commissions 
of Development and Reform, and Population and 
Family Planning, as well as law and policymakers from 
the State Council, visited many places, including 
Australia, the USA, Brazil, Thailand, Europe, and 
Africa. These tours provided an opportunity for offi  cials 
to learn from their counterparts in other countries, as 
well as promoting relationships between the diff erent 
Chinese government sectors that participated in the 
study tours.
Workshops that involved key government agencies 
were also held within China to further foster cross-sector 
communications. The organisation of Chinese govern-
ment services is traditionally hierarchical and depart-
ment alised, not directly cultivating cooperation and 
collaboration across sectors. This tradition made the 
organisation of multifaceted responses appropriate for 
HIV/AIDS control diffi  cult. The WHO Global 
Programme on AIDS, and subsequently UNAIDS, 
together with other UN agencies in Asia and the Pacifi c, 
such as the UN Drugs Control Programme (now the UN 
Offi  ce of Drugs and Crime), had important roles in 
working with the government of China to organise and 
facilitate cross-sector discussions. 
One workshop in particular was pivotal in pushing 
policies to support interventions that targeted high-risk 
groups in China. Held in 1997 and organised by the 
Chinese Academy of Preventive Medicine (renamed the 
Chinese Centre for Disease Control and Prevention 
[CDC] in 2002) and the University of California at Los 
Angeles, the workshop drew together scholars from 
sociology, ethics, public health, and education, as well as 
government offi  cials and representatives of international 
agencies such as WHO, UN, and the World Bank. This 
workshop was the fi rst open discussion of evidence-based 
but controversial intervention strategies that targeted 
those at high risk of HIV infection who were also highly 
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stigmatised—eg, sex workers, IDUs, and men who have 
sex with men. Although controversial—pitting scientifi c, 
evidence-based prevention approaches against conser-
vative, moralistic attitudes—the consensus acknow-
ledged the possible benefi t of the implementation of 
new prevention strategies. 
Members of these various workshops and study tours 
have been responsible for the identifi cation of eff ective 
strategies that have increasingly been at the forefront of 
HIV control policy in China. They have also contributed 
to the development of strategic documents, including 
the Medium- and Long-Term Strategic Plan for 
HIV/AIDS (1998–2010),21 the Action Plan on HIV/AIDS 
Prevention and Containment (2001–2005),22 and the 
AIDS Regulations.1 Other key documents warned of the 
potential epidemic in China and might have infl uenced 
the attitudes of policymakers. China’s Titanic Peril,23 
published by the UN in 2002, made the unsubstantiated 
prediction that China could have 10 million HIV-infected 
individuals by 2010, a fi gure that has been repeatedly 
misused in discussions of China’s HIV future. A Joint 
Assessment of HIV/AIDS Prevention, Treatment and 
Care in China (2004),8 developed jointly by UNAIDS 
and the State Council of China, estimated that China 
had 840 000 people living with HIV/AIDS. This fi gure 
has been revised down to 650 000 in 2005 in light of 
more representative data collection and more 
appropriate estimation methods.9 Although this fi gure 
represented a prevalence of about 0·05%, it was 
substantially higher than previous government 
estimates (300 000 in 199821) and provided the impetus 
for immediate scale-up of prevention and control 
strategies. 
Scientifi c evidence for innovative policies
Concurrent with educational activities and network 
building for government offi  cials, Chinese researchers 
identifi ed the key risk groups, documented and predicted 
the course of the epidemic, observed successful pro-
grammes in other countries, and tested the eff ectiveness 
of behavioural interventions. HIV-related research 
projects were done by universities, hospitals, and 
community agencies, both independently and as 
collaborative projects with other domestic and 
international institutions. Most research and surveillance 
commissioned by the Chinese government is done by 
the National Centre for AIDS/STD Control and 
Prevention (NCAIDS) at the Chinese CDC. At the local 
level, almost all HIV research and intervention—
whether done by the Chinese CDC or other research 
organisations—is done in collaboration with provincial 
and county CDCs, township hospitals, and village health 
workers. Research initiated by the Chinese CDC 
administrators, especially that commissioned by the 
Ministry of Health, is diff used and implemented faster 
than research done outside the existing government 
structure. 
Reduction of transmission via injecting drug use
Intravenous drug use represents the largest single 
cause of HIV transmission in China, accounting for 
44·3% of infections at the end of 2005.9 Ministry of 
Public Security data suggests that the number of 
registered drug users has risen steadily at a rate of 
about 122% per year, from 70 000 in 1990 to 1·16 million 
in 2005. The total number, including unregistered drug 
users, is thought to be much higher, with one estimate 
placing the fi gure at 3·5 million;24 the UNODC World 
Drug Report estimated that in 2003, 0·2% of 16–64-year-
olds (ie, 1·7 million people) were opiate abusers.25 The 
most commonly used drug is heroin, which accounts 
for 85% of total reported drug use, although 
amphetamines are becoming more common, especially 
in urban areas.26 Many drug users begin heroin use by 
smoking, but later fi nd it more cost eff ective to inject 
because of the stronger eff ect gained from injecting a 
smaller amount. Sharing injection equipment is 
common.27 
National policymakers have recently shifted their 
position and publicly acknowledged the extent and 
pattern of increasing drug use, which has led to a rapid 
increase in treatment options for drug users. According 
to the regulations on the prohibition of narcotics,15 drug 
users identifi ed by authorities for the fi rst time are fi ned 
or sent to a voluntary detoxifi cation centre run by the 
health system, which might include short-term use of 
methadone, buprenorphine, or traditional Chinese 
medicine. De toxifi cation costs 2000–5000 yuan (about 
US$250–625) for one phase of treatment.28,29 If, as often 
happens, the treatment is not successful, relapsing 
patients identifi ed by authorities are sent to a compulsory 
rehabilitation centre, administered by the Ministry for 
Public Security, for 3–6 months. Those with multiple 
relapses are detained in a re-education-through-labour 
centre, managed by the Ministry of Justice, for 1–3 years. 
In reality, internment procedures and durations vary 
enormously between administrative units. In general, 
centres focus on detoxifi cation. Although some health 
education or treat ment is provided, the relapse rate is 
extremely high.30–32
Cooperative actions by politicians, policymakers, 
government offi  cials, and scientifi c researchers have 
resulted in the introduction of new strategies for drug 
control over the past 6 years. For example, the 
government is working with neighbouring countries to 
prevent drug smuggling, and is increasing anti-drug 
education for the general population and in schools.29 
The government has also commissioned research on 
harm reduction strategies, such as methadone 
maintenance treatment and needle exchange pro-
grammes.
Needle exchange programmes
Needle exchange programmes are not a strategy 
offi  cially sanctioned by the Ministry for Public Security 
Public Health
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since such strategies give the appearance of condoning 
drug use. Thus, when this strategy was fi rst introduced, 
it was called needle social marketing—increasing the 
commercial availability and accessibility of needles in 
combination with health education about safe injecting 
practices and, in some cases, provision of free needles.27 
Since 2001, the State Council has offi  cially advocated 
needle social marketing as an HIV prevention 
measure.22 Evidence from research and study tours to 
countries such as Australia,33 which runs successful 
needle exchange programmes, prompted the Ministry 
of Health to support the fi rst such programme in 
Yunnan province and Guangxi Zhuang Autonomous 
Region in 1999. In 2000–02, a larger intervention trial 
of needle exchange programmes was done in four 
counties of Guangdong province and Guangxi, funded 
by the World AIDS Foundation.34,35 Cross-sectional data 
gathered at follow-up indicated that participants in 
intervention communities were almost three times less 
likely to have shared needles in the past month than 
those in control communities (odds ratio 0·36, 95% CI 
0·25–0·52). Furthermore, rates of infection with 
hepatitis C virus were signifi cantly lower in the 
intervention arm than in the control arm (51·1% vs 
83·6%, p=0·001) and HIV rates were lower in the 
intervention arm; however, this was signifi cant only in 
Guangdong (p=0·011) and not in Guangxi (p=0·2) nor 
overall (18·1% vs 23·6%, p=0·391). 
The results of the trial were used to develop national 
policy guidelines in 2002, and needle exchange pro-
grammes have been included in the second 5-year 
action plan.2 The programme was substantially scaled-
up in 2006, from 93 sites to 729 by the year’s end. 
Scale-up has been focused in rural areas, and in many 
places additional services are off ered to IDUs, including 
condom distribution, voluntary counselling and testing, 
anti retroviral therapy, and educational information 
about drug use and HIV.36 
Methadone maintenance treatment programmes
A large body of international research has shown the 
effi  cacy of methadone maintenance treatment pro-
grammes for the treatment of drug addiction and 
subsequent reduction in HIV risk behaviours.37–40 In 
acknowledgment of this evidence, in 2004 the Chinese 
government called for the use of such practices to 
mitigate HIV transmission.41 Immediately, under the 
governance of the Ministries of Health and Public 
Security and the State Food and Drug Administration, a 
pilot study of eight clinics in fi ve provinces was done.42,43 
Inclusion in the programme required: (1) several failed 
attempts to quit the use of heroin, (2) at least two terms 
in a detoxifi cation centre, (3) age at least 20 years, 
(4) being a registered local resident of the area in which 
the clinic is located, and (5) being of good civil character. 
Those testing HIV positive need only fulfi l criteria 
4 and 5. To monitor the progress of the clinics, a database 
was established to gather data on demographics, medical 
issues, drug use, and other information about the 
patients. These data were assessed at 3, 6, and 12 months, 
and indicated reductions in heroin use, drug-related 
crime, and unemployment in those who received 
methadone maintenance treatment (fi gure 3).
On the basis of the successes of the pilot, the programme 
began scale-up in 2004 and plans are in place to open an 
additional 1500 methadone maintenance treatment clinics 
for about 300 000 heroin users by 2008. A National 
Training Centre for methadone maintenance treatment 
has been established in Yunnan to provide clinical and 
technical support. The services off ered at such clinics have 
been broadened and provide access to other services, 
including HIV and hepatitis testing, antiretroviral therapy 
for eligible AIDS patients, group activities, and skills 
training for employment. The use of methadone 
maintenance therapy has been incorporated into the AIDS 
Regulations as a treatment for heroin addiction. 
Additionally, the requirements for entrance into 
methadone maintenance treatment programmes have 
been relaxed to encourage greater access. For example, 
patients are no longer required to have local residency or a 
previous history of internment in a detoxifi cation centre. 
The programme is not without problems, however, and 
retaining drug users in the programme remains a critical 
challenge. 
Sexual transmission
Although most HIV-infected individuals in China are 
drug users, patients infected through sexual trans-
mission are the fastest growing group, accounting for 
close to 50% of new infections in 2005.9 Overall, they 
represent 43·6% of total HIV/AIDS cases, including 
commercial sex workers or their clients (19·6%), 
partners of HIV-infected individuals (16·7%), and men 
who have sex with men (7·3%).9 As with drug use, 
sexuality is not openly discussed in Chinese society and 
is therefore neither easily targeted by health promotion 
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campaigns, nor has it traditionally been taught in 
schools. Even among university students, levels of AIDS 
knowledge and risk perception are alarmingly low.44,45 
On the other hand, attitudes towards sex are becoming 
increasingly more liberal and, as a result, premarital 
and extramarital sex are more commonly practised.46,47 
Although they are widely available, condoms are rarely 
used.48 
Commercial sex work
Commercial sex work is illegal in China; hence, brothels 
are illegal and commercial sex workers operate out of 
places of entertainment (eg, karaoke bars), hotels, 
hair-dressing salons, or on the street.49 The traditional 
strategy for controlling HIV transmission through 
commercial sex workers has been the development of 
stricter laws to prevent risky behaviours,16 accompanied 
by raids on suspected sex establishments by public 
security offi  cials.20,49 Those apprehended are subject to 
compulsory education on law and morality, testing and 
treatment for sexually transmitted diseases,49 and forced 
participation in productive labour.20 Under the Frontier 
Health and Quarantine Law,12 those knowingly infected 
with HIV who continue to practise prostitution are 
subject to more severe penalties and criminal liability 
for creating a risk of spreading a quarantinable 
disease.12,49 Detention ranges from 6 months to 2 years. 
Until recently, health education in this system was 
uncommon. 
In 1996–97, following the success of prevention 
interventions in neighbouring Thailand,50 the Chinese 
CDC launched the fi rst intervention projects to promote 
safer sex behaviours to prevent HIV and other sexually 
transmitted diseases in commercial sex workers working 
at entertainment establishments in Yunnan.51,52 These 
projects showed the feasibility of such programmes, 
which included condom use to control the spread of 
HIV and other sexually transmitted diseases in com-
mercial sex workers, and have been offi  cially promoted 
since 1998.21 Between 1999 and 2001, the World AIDS 
Foundation supported a fi ve-site trial of a behavioural 
intervention in commercial sex workers who worked in 
entertainment establishments.54,55 The intervention 
included condom promotion, establishment of clinics 
for sexually trans mitted diseases to provide check-ups, 
and outreach for health education and counselling. 
HIV-related knowledge improved sub stantially, and the 
rate of bacterial sexually transmitted diseases fell. The 
rate of condom use at last intercourse increased from 
around 55% to 68%, and fewer commercial sex workers 
agreed to sex without a condom when requested by a 
client who off ered more money. The prevalence of 
gonorrhoea fell from about 26% at baseline to 4% after 
intervention, and the prevalence of chlamydia fell from 
about 41% to 26%.
The fi ndings from this trial were used to draft national 
guidelines for interventions among sex workers in 
China. The provision of condoms at entertainment 
estab lishments is now an offi  cial requirement under the 
AIDS Regulations. Condom vending machines are 
being installed in venues such as university campuses 
and hotels, and condom promotion and HIV education 
campaigns that target youth and migrant workers are 
gradually being scaled up.55,56
Infl uential forces
Changes in government
In 2003, a new administration led by President Hu Jintao, 
Premier Wen Jiabao, and Vice Premier and Health 
Minister Wu Yi substantially accelerated the commitment 
to and implementation of evidence-based HIV policies. 
Under this administration, a number of initiatives have 
been introduced: the China Comprehensive AIDS 
Response (China CARES), which assists 127 high-
prevalence counties in providing care and support to 
people living with HIV/AIDS; the “Four Free and One 
Care” policy (panel); and the formation of a State Council 
AIDS Working Committee responsible for the 
development of a comprehensive policy framework (eg, 
the Notice on Strengthening HIV/AIDS Prevention and 
Control).8 New policies, supported by expanded budgets, 
have been intro duced (fi gure 4), which has permitted a 
substantial acceleration in programme development, 
testing, and scale-up.
Media
The media have exerted substantial infl uence over the 
timing and course of HIV control in China by bringing 
news of HIV to the attention of the public, administrators, 
and policymakers. In 1996, the Southern Weekend news-
paper ran a front-page story and devoted another two 
pages to AIDS in China. This coverage was the fi rst time 
any comprehensive exposure of the HIV/AIDS epidemic 
in China had been published by the Chinese press. 
From 1999, the international and subsequently the 
national media reported on the thousands of infected 
plasma donors in Henan and neighbouring provinces 
who did not have access to services. Although the 
government had acted quickly when the tragedy became 
apparent in 1995 by shutting down collection stations 
and, later, introducing new laws and regulations on the 
collection and manage ment of blood and blood 
products,6,57,58 provision of HIV testing, prevention, and 
Panel: Chinese government “Four Free and One Care” policy for AIDS control
• Free antiretroviral drugs to AIDS patients who are rural residents or people without 
insurance living in urban areas.
• Free voluntary counselling and testing. 
• Free drugs to HIV-infected pregnant women to prevent mother-to-child transmission, 
and HIV testing of newborn babies.
• Free schooling for AIDS orphans.
• Care and economic assistance to the households of people living with HIV/AIDS.
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care for donors in the local areas was slower. Progress 
was stimulated by the media’s attention to the plight of 
the infected plasma donors. Since these initial reports, 
the HIV/AIDS situation in China has received much 
attention from the local and international media. 
Severe acute respiratory syndrome
The challenge of managing the severe acute respiratory 
syndrome (SARS) epidemic in 2003 is often credited with 
further motivating the government to take aggressive 
policy action on HIV-related issues. SARS showed not 
only how infectious diseases could threaten economic 
and social stability but also the eff ect of China’s policies 
on international health problems.19 Policymakers an-
nounced a change of focus from purely economic goals 
to increasing the focus on health and social wellbeing 
and, as a result, increased support for public-health 
agencies. In controlling SARS, contact between the 
govern ment and international agencies such as WHO, 
UN, and the US Centers for Disease Control and 
Prevention was essential and further stimulated stronger 
international collaboration for HIV/AIDS prevention and 
treatment. Intervention strategies necessary for SARS 
control have been translated into HIV/AIDS prevention—
eg, real-time electronic case reporting.
Programme scale-up
Case fi nding
The fi rst step in understanding the extent of an 
epidemic is to be able to identify cases. National sentinel 
surveillance has been implemented since 1995, but was 
initially restricted to high-risk areas and to attendees at 
sexually transmitted disease clinics, female sex workers, 
drug users, and long-distance truck drivers. Surveillance 
has gradually been expanded to 845 national sites and 
now also includes pregnant women and men who have 
sex with men.
Around the same time, voluntary testing and 
counselling was made available in some communities, 
but, even where available, was rarely used. Reluctance to 
seek HIV testing was probably due to a number of 
causes—eg, cost, inaccessibility of services, absence of 
any treatment, scant publicity or advocacy for testing, low 
or no perceived risk, and stigma associated with the use 
of testing services.59–62 In the past 3 years, the government 
has addressed the environmental barriers. The high cost 
was addressed in 2003 by making free HIV testing 
available for the poor,63 and later, under the Four Free and 
One Care policy, antiretroviral treatment was made freely 
available for all through the Chinese health system. The 
number of screening laboratories has been expanded 
to 5500, and there are now 99 laboratories able to do 
confi rmatory HIV tests. Free HIV testing has been made 
available, and expanded from 365 counties in 15 provinces 
in 2002 to over 2300 counties, with 3037 sites, in all 
provinces in 2006. The AIDS Regulations have introduced 
penalties for health units that do not provide free testing 
on request. 
The rapid expansion of testing infrastructure has 
been largely prompted by the introduction of 
provider-initiated routine testing campaigns to identify 
infected individuals and put them in contact with 
treatment services. Client-initiated testing was failing 
to identify most infected individuals, so campaigns to 
screen high-risk groups, including drug users, 
commercial sex workers, prisoners, and former plasma 
donors, were commissioned to link patients to treatment 
services.64 The campaigns have resulted in a substantial 
increase in the number of individuals who know their 
HIV status, with an additional 60 000 people living with 
HIV/AIDS identifi ed. This increased identifi cation 
explains, at least in part, the rapid rise in reported HIV 
cases in the early 21st century (fi gure 2). However, even 
with this eff ort, only about 22% of the estimated 
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Figure 4: Chinese central government spending on HIV/AIDS by year, 1985–2005
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650 000 HIV-infected individuals living in China at the 
end of 2005 have been identifi ed.9 Routine testing in 
high-risk groups continues. 
Educating the public
Testing campaigns were accompanied by community-level 
social marketing to raise awareness of HIV and to reduce 
HIV-related stigma. The AIDS Regulations have outlined 
requirements for local governments at the county level and 
above, as well as for educational establishments, 
businesses, health providers, customs and border control, 
and the media to promote HIV/AIDS education and social 
marketing. A number of schools now include sex, drug, 
and HIV education for their pupils, especially in high-risk 
areas such as Yunnan, Guangxi, and Guangdong. 
An important part of HIV education is targeting 
behaviour to reduce stigma towards people with 
HIV/AIDS. Stigma is well recognised as a major barrier 
to HIV control, because it prevents people from seeking 
services for testing and treatment, and discourages 
people from practising safer behaviours.59,65,66 To address 
this issue, senior political fi gures have been involved in 
anti-discrimination campaigns, and have publicly shown 
that HIV cannot be transmitted through casual contact. 
For example, on World AIDS Day, Dec 1, 2003, Premier 
Wen Jiabao publicly shook hands with AIDS patients in 
Beijing Ditan Hospital.67 The day before the 2004 World 
AIDS Day, President Hu Jintao and other senior 
government leaders visited patients living with 
HIV/AIDS and called for the elimination of bias against 
this group.68 During the Chinese New Year celebrations 
in 2005, Premier Wen Jiabao visited the homes of 
HIV-infected villagers in Henan province. These actions 
had a tremendous eff ect on the general community, and 
have now been backed up by policy changes. The AIDS 
Regulations have made it illegal to discriminate against 
people living with HIV/AIDS and their families in terms 
of their rights to schooling, employment, health services, 
and participation in community activities. Furthermore, 
the AIDS Regulations and the 2004 revision of the Law 
on the Prevention and Treatment of Infectious Disease69 
include language to protect the identity and disease 
status of those with an infectious disease, with 
disciplinary action recommended for those individuals 
or institutions that violate these laws. Although there 
had been language in previous regulations to protect the 
rights of people living with HIV/AIDS, these new laws 
give such individuals and their families a stronger basis 
from which to defend their rights.
Antiretroviral treatment for people with HIV/AIDS
In 2001 and 2002, the number of patients living with 
HIV/AIDS being identifi ed through treatment services 
began to increase. As many as 69 000 of these people 
were the rural poor who had been infected when they 
sold their blood and plasma in the mid-1990s and who 
were unable to access or aff ord much-needed anti-
retroviral treatment.9 On the basis of the successes of 
programmes in other nations, such as Brazil,70 a free 
antiretroviral therapy programme was piloted in late 
2002 in Shangcai county, Henan province, one of the 
most severely aff ected areas.71 Patients were provided 
with a combination of zidovudine or didanosine plus 
lamivudine and nevirapine. On the basis of the improved 
health status and survival of the initial cohort, the 
programme was scaled up in early 2003, mainly through 
the China CARES programme.71 
The provision of free antiretroviral therapy to rural 
residents and the urban poor became policy in 2003 
under the Four Free and One Care policy (fi gure 4).67 The 
National HIV/AIDS Clinical Taskforce took the lead in 
establishing the programme, and set up a database to 
monitor it.71 As of the end of 2006, more than 
30 640 patients have been treated in 800 counties in 
all 31 provinces. Research to inform further expansion 
and improvement of the programme is ongoing. Initial 
reports indicate that the current treatment regimen has 
a high drop-out rate (at least 8%), mainly due to 
side-eff ects, drug resistance, diffi  culty with adherence, 
and progression of disease.71 Therefore, the government 
is exploring options within the pharmaceutical industry 
to make additional regimens available,41 which will 
address both the issues of compliance, by making 
regimens with fewer side-eff ects available, and resistance, 
by making available additional lines of treatment.
Prevention of mother-to-child transmission
After reports of successful intervention in other 
developing countries,72 a feasibility trial of the prevention 
of mother-to-child transmission was piloted in late 2002 
concurrent with the antiretroviral therapy pilot, with 
fi nancial and technical support from UNICEF. Mothers 
who tested HIV positive were off ered counselling, the 
option of abortion or antiretroviral therapy and, where 
available, caesarean delivery, to reduce the likelihood of 
mother-to-child transmission. Free formula milk for 
12 months was provided for infants.73
On the basis of this pilot programme, national 
guidelines were developed to guide the prevention of 
mother-to-child transmission in the country. The 
provision of such services has been ratifi ed by the AIDS 
Regulations. Services are being scaled up to cover at least 
85% of infected pregnant women by 2007, and to reach at 
least 90% by 2010.2 Scale-up is being prioritised to the 
most heavily aff ected areas fi rst. As of the end of 2005, 
more than 500 000 pregnant women in high-risk groups 
or in high-prevalence areas had been tested for HIV in 
271 counties in 28 provinces. The overall participation 
rate in HIV testing in these pregnant women was 92%, 
and the HIV infection rate ranged from 0·3% to 0·7%. 
Among those who tested positive, 80% received 
antiretroviral therapy, and more than 90% accepted 
formula milk for the prevention of mother-to-child 
transmission.74
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Planned programmes
Unlike prostitution and drug use, homosexuality has 
never been banned in China, but it was listed as a 
psychiatric disorder until 2001, and public acts of 
homosexual sex are punishable as hooliganism.75 
Although increasingly tolerated in the cities, in general, 
homosexuality is highly stigmatised and men who have 
sex with men are under considerable pressure to 
conceal their sexual orientation.76 As a result, most 
homosexuals are married, or will be in the future, and 
form a bridge between the high-risk men who have sex 
with men group to their low-risk wives and other 
partners.75,77,78 The government has initiated few 
interventions for men who have sex with men, leaving 
such programmes to advocacy groups, non-
governmental organisations (NGOs), and researchers.79 
However, the government recently estimated that there 
were 5–10 million men who have sex with men living in 
China, of whom 1·35% are thought to be HIV positive.80 
This information, in addition to studies indicating low 
levels of HIV knowledge, perceived risk, and testing, 
and high rates of sexually transmitted diseases,61,81,82 has 
prompted the Ministry of Health to now include men 
who have sex with men in the high-risk groups and to 
call for the development of novel interventions to target 
them.83
Challenges ahead
China has made impressive progress in the development 
and implementation of eff ective intervention strategies, 
especially in the past 3 years. The country is currently in 
a transition stage in its HIV policy development. It is 
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increasingly adopting approaches that are based on 
scientifi c evidence and has encouraged the pilot testing 
of controversial methods of risk reduction (eg, 
methadone maintenance treatment, needle exchange 
programmes, and the targeting of men who have sex 
with men and sex workers).
Failures in scaling-up HIV prevention programmes 
have not been caused by an absence of policy, but rather, 
as with other countries, by there being no policy 
enforcement and timely scale-up. Although China has a 
strong central government, provincial and lower levels of 
government enjoy a great deal of autonomy, which has 
resulted in a mixed response and inconsistent 
enforcement of HIV/AIDS policy. For example, Yunnan 
province has shown strong support for implementation 
and advocacy of harm-reduction strategies that reduce 
HIV transmission in its many drug users, whereas Henan 
province had been slower to respond to the needs of 
former plasma donors in the early stages of the epidemic.84 
Moreover, the distribution of HIV in China is not even, 
and is concentrated in areas with high drug use (eg, 
Yunnan, Guangxi, Xinjiang, and Sichuan) and in areas 
where people were infected through unsafe blood or 
plasma donation (eg, Henan, Anhui, Hebei, Shanxi, and 
Hubei). The number of cases ranges dramatically between 
provinces (fi gure 5), with, for example, just 20 cases 
reported from Tibet but well over 40 000 in neighbouring 
Yunnan. In provinces with an extremely low prevalence, 
it can be diffi  cult for offi  cials to see the need for HIV 
prevention and control. 
Confl icts of interest between departments, such as those 
responsible for health and public security, have also made 
coordination of services to reach high-risk groups that 
engage in illegal behaviour diffi  cult.85 The central govern-
ment has called for greater cooperation between relevant 
departments—including Public Security, Justice, Edu- 
cation, Civil Aff airs, and Health—but implementation of 
this policy at the local level varies. 
The problem is further exacerbated by inadequate 
resources and trained personnel. Many rural areas—
where most of China’s HIV-positive population 
resides—do not have the capacity to monitor patients’ 
CD4+ cell counts and viral load. In some cases, the 
physical infrastructure exists, but staff  do not have the 
skills or reagents to use it. Human resource capacity is a 
major constraint on China’s ability to deliver HIV 
prevention and care. Many health workers and educators 
have poor knowledge of HIV and hold their own biases 
and stigmas towards those at risk or infected with 
HIV.86–88 A substantial proportion of the funds allocated 
to HIV prevention and control is being spent on 
establishing training centres and in building the capacity 
of health workers so that they can deliver better services. 
But many of those willing to work in rural areas do not 
have formal medical qualifi cations to begin with, which 
limits their abilities to understand the complexities of 
treating HIV patients.89 Furthermore, health services 
rely heavily on user fees, which often encourages health 
workers to do additional, chargeable services that many 
people living with HIV/AIDS cannot aff ord.90 
With an estimated 650 000 people living with HIV/
AIDS and an ever greater number of people at risk of 
infection, the government has embarked upon a 
formidable task. The provision of accessible testing and 
treatment services not only requires fi nancial resources, 
but also, in many cases, reorganisation and 
supplementary funding of existing local health services 
infrastructure, especially in rural areas where most of 
Chinese HIV-positive individuals reside.91 In particular, 
rural areas do not have adequately trained staff  capable 
of providing eff ective treatment and prevention services, 
as well as the laboratory and clinical infrastructure 
necessary to monitor treatment.71 The problem of 
inadequate human resources is not restricted to health 
departments—in rural areas, there are few adequately 
trained technical and management personnel at all 
levels and across all sectors. The combination of 
insuffi  ciently trained staff , inadequate technical 
resources, and a largely remote, poorly educated, rural 
population represents a challenge to the implemen-
tation of eff ective programmes.
A major step has been the government’s promotion 
of NGOs,92 which are a new concept in China.93 Many of 
the larger domestic groups are actually government 
funded, and those not affi  liated with the government 
are required to go through a complicated registration 
procedure to be offi  cially endorsed, although there 
might be a relaxation of these policies in the future.94 
The presence of international NGOs is also increasing. 
The ability of NGOs to work with high-risk groups, 
especially those that engage in behaviours deemed to 
be illegal or immoral, and to provide care and outreach 
where overstretched health services cannot, is 
recognised.95 The private sector is also being encouraged 
to undertake prevention and education activities.96
Conclusion
What has allowed the mobilisation of multiple sectors 
within China? First, over a 15-year period there was a 
long series of educational workshops, conferences, 
collaborative projects, and networking between mem-
bers at a number of levels of the government and 
administrative structural hierarchies. At local, national, 
and international forums, offi  cials from many sectors 
were able to meet one another, share a common 
knowledge base, and debate the appropriateness of 
diff erent interventions. Personal relationships were 
formed that facilitated the consideration and examination 
of previously unrecognised policy options for detection, 
prevention, and care. In a non-linear process, a 
consensus slowly evolved, identifying policy options. 
Second, political offi  cials, policymakers, administrators, 
and service providers were increasingly willing to 
recognise the relevance of a substantial body of scientifi c 
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research that suggested eff ective intervention strategies 
that could change the course of the epidemic. Third, 
major policy recommendations with regard to 
behavioural interventions were preceded by small pilot 
projects that showed feasibility or effi  cacy in those 
populations at highest risk. Fourth, once the evidence 
base was documented, both the policymakers and 
politicians publicly showed their support for HIV 
prevention and care, as well as passing legislation to 
enforce and broadly disseminate health practices (eg, 
routine HIV testing and access to care). 
These processes occurred in a context of ongoing 
infl uences from the media and international donor 
agencies, with some contribution from advocacy groups 
within China. The SARS epidemic showed the potentially 
disastrous eff ect of a fast-moving infectious disease and, 
simultaneously, allowed the HIV community to acquire 
new methods to fi ght the epidemic (eg, real-time data 
collection of new cases). However, mobilisation of 
resources, scientifi c evidence, and administrative drive 
did not occur until there was enthusiastic political 
commitment. The pace of implementation of innovative 
strategies for HIV detection, prevention, and care, 
accelerated with the commitments made by the govern-
ment of Hu Jintao, starting in 2003. 
After a slow start and reluctance to recognise the 
existence of risk activities in its population and of the 
HIV epidemic, China has responded to international 
infl uences, media coverage, and scientifi c evidence to 
take bold steps to control the epidemic, using scientifi cally 
validated strategies. The country now faces the challenge 
of scaling up these programmes and of convincing all 
levels of government to implement these innovative 
strategies and policies. This vigorous response, 
incorporating research fi ndings into policy formulation, 
can be informative to other countries that face similar 
challenges in responding to the HIV/AIDS epidemic.
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